The University of Southampton
University of Southampton Institutional Repository

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
Purpose: An assay for the single nucleotide polymorphism (SNP) rs61764370 has recently been commercially marketed as a clinical test to aid ovarian cancer risk evaluation in women with family histories of the disease. rs67164370 is in a 3'UTR miRNA binding site of the KRAS oncogene, and is a candidate for epithelial ovarian cancer (EOC) susceptibility. However, only one published paper, analyzing fewer than 1,000 subjects in total, has examined this association.

Experimental Design: Risk association was evaluated in 8,669 cases of invasive EOC and 10,012 controls from nineteen studies participating in the Ovarian Cancer Association Consortium, and in 683 cases and 2,044 controls carrying BRCA1 mutations from studies in the Consortium of Investigators of Modifiers of BRCA1/2. Prognosis association was also examined in a subset of five studies with progression-free survival data and eighteen studies with all-cause mortality data.

Results: No evidence of association was observed between genotype and risk of unselected EOC (odds ratio (OR)=1.02, 95% confidence interval (CI)=0.95-1.10), serous EOC (OR=1.08, 95%CI=0.98-1.18), familial EOC (OR=1.09, 95%CI=0.78-1.54), or among women carrying deleterious mutations in BRCA1 (OR=1.09, 95%CI=0.88-1.36). There was little evidence for association with survival time among unselected cases (hazard ratio (HR)=1.10, 95%CI=0.99-1.22), among serous cases (HR=1.12, 95%CI=0.99-1.28), or with progression-free survival in 540 cases treated with carboplatin and paclitaxel (HR=1.18, 95%CI=0.93-1.52).

Conclusions: These data exclude the possibility of an association between rs61764370 and a clinically significant risk of ovarian cancer or of familial ovarian cancer. Use of this SNP for ovarian cancer clinical risk prediction therefore appears unwarranted.

1078-0432
Pharoah, P.D.P.
72233519-0a97-430d-9b68-267585ca7cb7
Palmieri, R.T.
c2e1a373-1af6-49ca-b09c-0420b7d0b1dd
Ramus, S.J.
af8ce21a-1dec-4da4-a8ea-3da51e666ef6
Gayther, S.A.
08ec2b68-2561-42ed-a3c6-1a71cf37c93e
Andrulis, I.L.
146ec7e9-2139-4097-9480-8830c21e3948
Anton-Culver, H.A.
137c1602-ad3b-445d-9ddc-d306d41abb94
Antonenkova, N.
82fd3a7e-6e9b-4831-aeee-eb7562c9f82b
Antoniou, A.C.
6dc040a0-bd30-4178-995b-ca6f237949e1
Beattie, M.S.
b027347b-f295-4e7d-9001-e2877ba0a495
Beckmann, M.
84fc50b8-1182-4135-8ee4-6fa31ab3f843
Birrer, M.J.
5574312a-c47b-437a-a279-9200b91e27b8
Bogdanova, N.
2472101f-064a-492a-8205-eea5ae5c81f2
Bolton, K.L.
fd0f3e9e-7c80-43c4-af30-1ab3118558bb
Brewster, W.
9ef916fb-380c-40d4-9bf9-67c030a6bcc5
Brooks-Wilson, A.
53256ef9-6a04-4001-a7c0-b3ed77c25ffa
Brown, R.
b9108870-6092-4963-b323-be7254c71976
Butzow, R.
7dade1fc-e030-4ae3-8d34-56a977095df2
Caldes, T.
8bffb6d3-12fd-4fb2-a6cf-37a5b9c5c59b
Caligo, M.A.
18869143-e3e7-49f5-ae75-4d37061518b0
Campbell, I.G.
ca276d62-3544-4264-9dd1-3212b1fe4df6
Chang-Claude, J.
148388a1-b116-4ebd-9d4a-190975ed0cfd
Chen, A.
28ea8af7-c45c-4f4b-b6f0-44fc81aab4fd
Chenevix-Trench, G.
e90da721-7c34-4695-902f-34496a53526f
Cook, L.S.
7dc15198-2a22-4616-b27f-5197e2ce6b28
Couch, F.J.
cf80080b-6123-4085-99cd-e682f0823efe
Cramer, D.W.
8a1329b4-cfe6-4ddf-a5cc-8da483615226
Cunningham, J.M.
7064cd6c-6574-40a2-9613-d2afb21a14c6
Despierre, E.
891387ee-26fb-482d-80fa-4eca1df11a13
Doherty, J.A.
d9a2a6d1-2c83-4f74-b063-d0d0c4bd2e29
Dork, T.
b7ef11f1-fa10-48ae-b88b-462ea80db21d
Durst, M.
cef90012-26c9-4a47-bb99-36f73422430f
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Ekici, A.B.
44ca45c0-3a86-4a3d-9266-ef6c2b3007d3
Fasching, P.A.
27eebdb3-353a-435d-8859-c7d9002a0ef2
de Fazio, A.
45ea15c1-93ef-4aa1-b978-8c1776744c3d
Fenstermacher, D.A.
22d74295-e732-455d-a307-3c412bfa358e
Flanagan, J.M.
8e349519-4bf2-42a6-8650-ff950f2a14a9
Fridley, B.L.
8e3ff47b-c084-458e-9116-cbcd8e50146a
Friedman, E.
3d30ff62-bca2-4859-b60e-3acceb0a863b
Gao, B.
f25f687b-a29c-46be-9f8e-9be3b7814ffd
Gentry-Maharaj, A.
df8f0fdd-d109-4712-a323-456c686e633e
Godwin, A.K.
7b6c036b-08f9-4447-8444-83e2a34e0fa2
Goode, E.
ab7fb309-c7d2-4108-a0d7-00a7a32c8a3d
Goodman, M.T.
e5310c38-1330-4b1e-bb47-b375247a7486
Gross, J.
7f730687-2465-4229-a9e8-618d72341e13
Hansen, T.V.O.
a50cc020-c437-499f-a261-1046da45da3a
Harnett, P.R.
841192a9-6013-4bd1-9691-23165939e4ce
Heikkinen, T.
b4b9d116-3253-4e12-84d2-0ddaede1db84
Hein, R.
a6d0a67b-b805-444f-93cf-3df365a2c198
Hogdall, C K.
db9ecaf1-9fbc-43b6-b0f5-7f7e954879c3
Study Group of BCFR Investigators
Pharoah, P.D.P.
72233519-0a97-430d-9b68-267585ca7cb7
Palmieri, R.T.
c2e1a373-1af6-49ca-b09c-0420b7d0b1dd
Ramus, S.J.
af8ce21a-1dec-4da4-a8ea-3da51e666ef6
Gayther, S.A.
08ec2b68-2561-42ed-a3c6-1a71cf37c93e
Andrulis, I.L.
146ec7e9-2139-4097-9480-8830c21e3948
Anton-Culver, H.A.
137c1602-ad3b-445d-9ddc-d306d41abb94
Antonenkova, N.
82fd3a7e-6e9b-4831-aeee-eb7562c9f82b
Antoniou, A.C.
6dc040a0-bd30-4178-995b-ca6f237949e1
Beattie, M.S.
b027347b-f295-4e7d-9001-e2877ba0a495
Beckmann, M.
84fc50b8-1182-4135-8ee4-6fa31ab3f843
Birrer, M.J.
5574312a-c47b-437a-a279-9200b91e27b8
Bogdanova, N.
2472101f-064a-492a-8205-eea5ae5c81f2
Bolton, K.L.
fd0f3e9e-7c80-43c4-af30-1ab3118558bb
Brewster, W.
9ef916fb-380c-40d4-9bf9-67c030a6bcc5
Brooks-Wilson, A.
53256ef9-6a04-4001-a7c0-b3ed77c25ffa
Brown, R.
b9108870-6092-4963-b323-be7254c71976
Butzow, R.
7dade1fc-e030-4ae3-8d34-56a977095df2
Caldes, T.
8bffb6d3-12fd-4fb2-a6cf-37a5b9c5c59b
Caligo, M.A.
18869143-e3e7-49f5-ae75-4d37061518b0
Campbell, I.G.
ca276d62-3544-4264-9dd1-3212b1fe4df6
Chang-Claude, J.
148388a1-b116-4ebd-9d4a-190975ed0cfd
Chen, A.
28ea8af7-c45c-4f4b-b6f0-44fc81aab4fd
Chenevix-Trench, G.
e90da721-7c34-4695-902f-34496a53526f
Cook, L.S.
7dc15198-2a22-4616-b27f-5197e2ce6b28
Couch, F.J.
cf80080b-6123-4085-99cd-e682f0823efe
Cramer, D.W.
8a1329b4-cfe6-4ddf-a5cc-8da483615226
Cunningham, J.M.
7064cd6c-6574-40a2-9613-d2afb21a14c6
Despierre, E.
891387ee-26fb-482d-80fa-4eca1df11a13
Doherty, J.A.
d9a2a6d1-2c83-4f74-b063-d0d0c4bd2e29
Dork, T.
b7ef11f1-fa10-48ae-b88b-462ea80db21d
Durst, M.
cef90012-26c9-4a47-bb99-36f73422430f
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Ekici, A.B.
44ca45c0-3a86-4a3d-9266-ef6c2b3007d3
Fasching, P.A.
27eebdb3-353a-435d-8859-c7d9002a0ef2
de Fazio, A.
45ea15c1-93ef-4aa1-b978-8c1776744c3d
Fenstermacher, D.A.
22d74295-e732-455d-a307-3c412bfa358e
Flanagan, J.M.
8e349519-4bf2-42a6-8650-ff950f2a14a9
Fridley, B.L.
8e3ff47b-c084-458e-9116-cbcd8e50146a
Friedman, E.
3d30ff62-bca2-4859-b60e-3acceb0a863b
Gao, B.
f25f687b-a29c-46be-9f8e-9be3b7814ffd
Gentry-Maharaj, A.
df8f0fdd-d109-4712-a323-456c686e633e
Godwin, A.K.
7b6c036b-08f9-4447-8444-83e2a34e0fa2
Goode, E.
ab7fb309-c7d2-4108-a0d7-00a7a32c8a3d
Goodman, M.T.
e5310c38-1330-4b1e-bb47-b375247a7486
Gross, J.
7f730687-2465-4229-a9e8-618d72341e13
Hansen, T.V.O.
a50cc020-c437-499f-a261-1046da45da3a
Harnett, P.R.
841192a9-6013-4bd1-9691-23165939e4ce
Heikkinen, T.
b4b9d116-3253-4e12-84d2-0ddaede1db84
Hein, R.
a6d0a67b-b805-444f-93cf-3df365a2c198
Hogdall, C K.
db9ecaf1-9fbc-43b6-b0f5-7f7e954879c3

Pharoah, P.D.P., Palmieri, R.T., Ramus, S.J., Gayther, S.A., Andrulis, I.L., Anton-Culver, H.A., Antonenkova, N., Antoniou, A.C., Beattie, M.S., Beckmann, M., Birrer, M.J., Bogdanova, N., Bolton, K.L., Brewster, W., Brooks-Wilson, A., Brown, R., Butzow, R., Caldes, T., Caligo, M.A., Campbell, I.G., Chang-Claude, J., Chen, A., Chenevix-Trench, G., Cook, L.S., Couch, F.J., Cramer, D.W., Cunningham, J.M., Despierre, E., Doherty, J.A., Dork, T., Durst, M., Eccles, Diana, Ekici, A.B., Fasching, P.A., de Fazio, A., Fenstermacher, D.A., Flanagan, J.M., Fridley, B.L., Friedman, E., Gao, B., Gentry-Maharaj, A., Godwin, A.K., Goode, E., Goodman, M.T., Gross, J., Hansen, T.V.O., Harnett, P.R., Heikkinen, T., Hein, R. and Hogdall, C K. , Study Group of BCFR Investigators (2011) The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research. (doi:10.1158/1078-0432.CCR-10-3405). (PMID:21385923)

Record type: Article

Abstract

Purpose: An assay for the single nucleotide polymorphism (SNP) rs61764370 has recently been commercially marketed as a clinical test to aid ovarian cancer risk evaluation in women with family histories of the disease. rs67164370 is in a 3'UTR miRNA binding site of the KRAS oncogene, and is a candidate for epithelial ovarian cancer (EOC) susceptibility. However, only one published paper, analyzing fewer than 1,000 subjects in total, has examined this association.

Experimental Design: Risk association was evaluated in 8,669 cases of invasive EOC and 10,012 controls from nineteen studies participating in the Ovarian Cancer Association Consortium, and in 683 cases and 2,044 controls carrying BRCA1 mutations from studies in the Consortium of Investigators of Modifiers of BRCA1/2. Prognosis association was also examined in a subset of five studies with progression-free survival data and eighteen studies with all-cause mortality data.

Results: No evidence of association was observed between genotype and risk of unselected EOC (odds ratio (OR)=1.02, 95% confidence interval (CI)=0.95-1.10), serous EOC (OR=1.08, 95%CI=0.98-1.18), familial EOC (OR=1.09, 95%CI=0.78-1.54), or among women carrying deleterious mutations in BRCA1 (OR=1.09, 95%CI=0.88-1.36). There was little evidence for association with survival time among unselected cases (hazard ratio (HR)=1.10, 95%CI=0.99-1.22), among serous cases (HR=1.12, 95%CI=0.99-1.28), or with progression-free survival in 540 cases treated with carboplatin and paclitaxel (HR=1.18, 95%CI=0.93-1.52).

Conclusions: These data exclude the possibility of an association between rs61764370 and a clinically significant risk of ovarian cancer or of familial ovarian cancer. Use of this SNP for ovarian cancer clinical risk prediction therefore appears unwarranted.

This record has no associated files available for download.

More information

Published date: 8 March 2011

Identifiers

Local EPrints ID: 180377
URI: http://eprints.soton.ac.uk/id/eprint/180377
ISSN: 1078-0432
PURE UUID: 77ad0367-f7d1-4b00-8abb-a00db92c45ed
ORCID for Diana Eccles: ORCID iD orcid.org/0000-0002-9935-3169

Catalogue record

Date deposited: 08 Apr 2011 12:59
Last modified: 15 Mar 2024 02:40

Export record

Altmetrics

Contributors

Author: P.D.P. Pharoah
Author: R.T. Palmieri
Author: S.J. Ramus
Author: S.A. Gayther
Author: I.L. Andrulis
Author: H.A. Anton-Culver
Author: N. Antonenkova
Author: A.C. Antoniou
Author: M.S. Beattie
Author: M. Beckmann
Author: M.J. Birrer
Author: N. Bogdanova
Author: K.L. Bolton
Author: W. Brewster
Author: A. Brooks-Wilson
Author: R. Brown
Author: R. Butzow
Author: T. Caldes
Author: M.A. Caligo
Author: I.G. Campbell
Author: J. Chang-Claude
Author: A. Chen
Author: G. Chenevix-Trench
Author: L.S. Cook
Author: F.J. Couch
Author: D.W. Cramer
Author: J.M. Cunningham
Author: E. Despierre
Author: J.A. Doherty
Author: T. Dork
Author: M. Durst
Author: Diana Eccles ORCID iD
Author: A.B. Ekici
Author: P.A. Fasching
Author: A. de Fazio
Author: D.A. Fenstermacher
Author: J.M. Flanagan
Author: B.L. Fridley
Author: E. Friedman
Author: B. Gao
Author: A. Gentry-Maharaj
Author: A.K. Godwin
Author: E. Goode
Author: M.T. Goodman
Author: J. Gross
Author: T.V.O. Hansen
Author: P.R. Harnett
Author: T. Heikkinen
Author: R. Hein
Author: C K. Hogdall
Corporate Author: Study Group of BCFR Investigators

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×